Replies to post #115500 on Biotech Values

[DewDiligence]

Phase-Transition Probabilities: Lead vs Secondary Indications

This chart shows the data from #msg-60339665
broken down by lead vs secondary indications.



Source: http://insidebioia.files.wordpress.com/2011/02/bio-ceo-biomedtracker-bio-study-handout-final-2-15-2011.pdf

[DewDiligence]

Drug-Development Success Rates in Oncology

This chart shows the probability of a drug’s regulatory approval from
the start of phase-1 for various cancer types. The overall success rate
in oncology is 4.7%, the lowest rate for any area of drug development.



Source: http://insidebioia.files.wordpress.com/2011/02/bio-ceo-biomedtracker-bio-study-handout-final-2-15-2011.pdf